INVENTING THE FUTURE OF MEDICINE
UW Bioengineering Assistant Professor Patrick Boyle and his collaborators in UW cardiology and epidemiology are developing a way to use artificial intelligence to help frontline health care workers predict which COVID-19 patients are at highest risk for heart complications from the illness.
Modern smartphone cameras can be harnessed to analyze and track skin changes and blood flow dynamics under the skin, report UW Bioengineering Professor Ruikang Wang and his graduate student Qinghua He, in the February issue of Biomedical Optics Express.
University of Washington bioengineers Ying Zheng and Cole DeForest, working with Seattle Children’s infectious disease researchers, have engineered tiny blood vessels and shed light on how severe malaria infection causes red blood cells to get stuck in the bloodstream’s narrowest passageways. Their paper is published in the Jan. 17 issue of Science Advances.
University of Washington Department of Bioengineering Allan S. Hoffman Lecture Presents Kristi S. Anseth, Ph.D. [...]
A recap of UW Bioengineering's efforts to empower better health care through biomedical research, education and service, and impact medicine, for Washington and for the world.
UW Bioengineering faculty member Cole DeForest joined the core faculty in January 2019 as joint assistant professor of chemical engineering and bioengineering. He brings expertise in applying synthetic chemistry and materials science to the department’s biomaterials, protein engineering and regenerative medicine research.
Bowen Li, a UW Bioengineering Ph.D. student, recently received the 2019 College of Engineering Student Award for Research. The award recognizes students who demonstrate merit in research through publications, external recognition and invited presentations, and through innovation and creativity.
Two ideas put forth by UW's Center for Dialysis Innovation (CDI) - a next-generation wearable dialyzer and a new vascular access graft - advanced to the finals in a national competition aimed at speeding innovations in prevention, diagnosis and treatment of kidney diseases.
Bioprinted tissues with entangled vascular networks for air and blood are a major step toward 3D printing of replacement organs. Bioengineers from University of Washington and Rice University teamed to create the 3D bioprinted vascular networks and tested them in mice.
Researchers led by UW Department of Bioengineering Professor Valerie Daggett have developed synthetic peptides that can target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. The team reports their achievement in a paper published the week of April 15 in the Proceedings of the National Academy of Sciences.
